분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-02-01 15:17:34 , Hit : 762
 CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect

GEN News
Jan 27, 2016
  
Skin cells from a patient with X-linked retinitis pigmentosa were transformed into induced pluripotent stem cells, and the blindness-causing point mutation in the RPGR gene was corrected using CRISPR/Cas9. [Vinit Mahajan, University of Iowa Health Care]  

Marking yet another CRISPR-related first, scientists have replaced a defective gene associated with a sensory disease in stem cells that were derived from a patient’s tissue. The disease, retinitis pigmentosa (RP), is an inherited condition that degrades the retina and leads to blindness. A patient with the disease supplied a skin sample that was used to generate the stem cells, which were manipulated by means of the CRISPR/Cas9 gene-editing system.

CRISPR/Cas9, which zeroed in on a single disease-causing mutation in the RGPR gene, was able to make the necessary correction in 13% of the stem cells. This correction rate, according to the Columbia University and University of Iowa scientists who announced the results, is indicative of a practical approach—albeit one that still needs work. The Columbia/Iowa team added that they are working to show that their technique does not introduce any unintended genetic modifications in human cells, and that the corrected cells are safe for transplantation.

While the scientists freely acknowledge that their technique needs additional development before any cures are possible, they basked in the success of having accomplished a difficult genetic fix. The RGPR mutation that needed to be repaired sits in a highly repetitive sequence of the gene where it can be tricky to discriminate one region from another. In fact, it was not clear that CRISPR/Cas9 would be able to home in on and correct the point mutation.

The scientists described their work January 27 in the journal Scientific Reports in an article entitled “Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells.”

“Fibroblasts cultured from a skin-punch biopsy of an XLRP patient were transduced to produce [induced pluripotent stem cells (iPSCs)] carrying the patient’s c.3070G > T mutation,” the authors wrote. “The iPSCs were transduced with CRISPR guide RNAs, Cas9 endonuclease, and a donor homology template. Despite the gene’s repetitive and GC-rich sequences, 13% of RPGR gene copies showed mutation correction and conversion to the wild-type allele.”

The authors asserted that theirs was the first report of CRISPR/Cas9 being used to correct a pathogenic mutation in iPSCs derived from a patient with photoreceptor degeneration. This proof-of-concept finding, they added, supports the development of personalized iPSC-based transplantation therapies for retinal disease.

The authors also emphasized that because the corrections are made in cells derived from the patient's own tissue, doctors can retransplant the cells with fewer fears of rejection by the immune system. Previous clinical trials have shown that generating retinal cells from embryonic stem cells and using them for transplantation is a safe and potentially effective procedure.

Recently, another group has used CRISPR to ablate a disease-causing mutation in rats with retinitis pigmentosa. Going forward, the first clinical use of CRISPR could be for treating an eye disease because compared to other body parts, the eye is easy to access for surgery, readily accepts new tissue, and can be noninvasively monitored.







947   바이오통신원 [바이오토픽] 이제는 염기편집 시대, Cas9를 변형하여 DNA 한 글자만 바꾼다.  이성욱 2016/04/21 1171
946   Hitting HIV with CRISPR/Cas9 Can Arouse Resistance  이성욱 2016/04/10 866
945   GSK Gets Positive CHMP Opinion For Strimvelis To Treat Rare Disease ADA-SCID  이성욱 2016/04/02 1036
944   CRISPR Can Tag RNA  이성욱 2016/03/26 801
943   미니멀세포(minimal cell)를 만든 크레이그 벤터  이성욱 2016/03/26 956
942   Minimal Genome Created  이성욱 2016/03/26 832
941   Using Gene Editing to Delete HIV from Human T Cells  이성욱 2016/03/23 774
940   RNA May Surpass DNA in Precision Medicine  이성욱 2016/03/23 821
939   Zika Update  이성욱 2016/03/15 756
938   CRISPR/Cas9을 이용하여 PRRS 바이러스에 감염되지 않는 돼지를 개발하다  이성욱 2016/03/14 1204
937   유전자 가위, 매머드 복원-안전한 백신의 시대 리본 자르다  이성욱 2016/03/14 990
936   Tunable Form of CRISPR Is an Efficient Regulator of Stem Cell Expression  이성욱 2016/03/14 700
935   NIH 연구진들은 5가지 종류의 암에서 공유되는 충격적인 게놈 상의 특징을 확인  이성욱 2016/03/09 829
934   특허전쟁: 미국 특허청, CRISPR의 특허권 중재 시작  이성욱 2016/03/08 1049
933   CRISPR Editing of Human Embryos Approved in the U.K.  이성욱 2016/02/02 808
  CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect  이성욱 2016/02/01 762
931   거대 바이러스에게서도 발견된 CRISPR 유사 시스템  이성욱 2016/03/02 1123
930   MIT 선정 2015년 주목받은 Biomedicine 뉴스  이성욱 2016/02/03 889
929   유전자치료제 연구개발 및 규제 동향 2015-식품의약품안전처  이성욱 2016/01/20 1066
928   융합연구리뷰 | Convergence Research Review  이성욱 2016/01/08 1057

[이전 10개] [1]..[11][12][13][14][15][16] 17 [18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN